Boone Drug chooses to not dispense Mifepristone

HIGH COUNTRY — Boone Drug will not participate in the voluntary Mifepristone Risk Evaluation and Mitigation Strategy Program due to the organization’s belief that it has a responsibility to protect

Related Keywords

Washington ,United States ,Matthew Kacsmaryk ,Corey Furman ,Mitigation Strategy Program ,Supreme Court ,Boone Drug ,Mifepristone Risk Evaluation ,Black Box Warning ,Drug President Corey Furman ,Judge Thomas Owens Rice ,Eastern District ,Law ,Medicine ,Harmacology ,Politics ,Rade ,Iology ,Hysiology ,